Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments

Simple item page
dc.contributor.authorKoyuncu F.M.
dc.contributor.authorKuscu N.K.
dc.contributor.authorVar A.
dc.contributor.authorOnur E.
dc.date.accessioned2024-07-22T08:24:43Z
dc.date.available2024-07-22T08:24:43Z
dc.date.issued2003
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1034/j.1600-0412.2003.00189.x
dc.identifier.issn00016349
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20085
dc.language.isoEnglish
dc.subjectAdministration, Oral
dc.subjectAdult
dc.subjectAndrogen Antagonists
dc.subjectContraceptives, Oral, Combined
dc.subjectContraceptives, Oral, Synthetic
dc.subjectCyproterone Acetate
dc.subjectDesogestrel
dc.subjectDrug Combinations
dc.subjectEstradiol Congeners
dc.subjectEthinyl Estradiol
dc.subjectFemale
dc.subjectGonadal Steroid Hormones
dc.subjectHumans
dc.subjectLeptin
dc.subjectPolycystic Ovary Syndrome
dc.subjectSex Hormone-Binding Globulin
dc.subjectSteroids
dc.subjectdesogestrel plus ethinylestradiol
dc.subjectdiane
dc.subjectfollitropin
dc.subjectinsulin
dc.subjectleptin
dc.subjectluteinizing hormone
dc.subjectmyralon
dc.subjectoral contraceptive agent
dc.subjectprasterone sulfate
dc.subjectsex hormone binding globulin
dc.subjectarticle
dc.subjectbody mass
dc.subjectclinical article
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectcorrelation analysis
dc.subjectenzyme linked immunosorbent assay
dc.subjectfemale
dc.subjecthormone determination
dc.subjecthuman
dc.subjectoral contraception
dc.subjectovary polycystic disease
dc.subjectpriority journal
dc.subjectprotein blood level
dc.subjectrandomized controlled trial
dc.titleLeptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments
dc.typeArticle

Files

Collections

Scopus Koleksiyonu